It uses the same semaglutide molecule as Rybelsus but at a significantly higher dose, and carries approval for obesity treatment and cardiovascular risk reduction in adults with overweight or obesity and established cardiovascular disease
And obesity medicine specialists and researchers have known this for a long time
That breadth matters if you want the brand version specifically, if you have a preference for an FDA-approved oral pill over a weekly injection, or if you want a single program where you can switch medications without changing providers
When weight reduction exceeds approximately 1.5 kg per week during early therapy, clinicians should remain alert
Ideally, this framework is further enriched with metagenomic analysis of the gut microbiome, which provides valuable insights for functional decision-making (Proctor et al., 2019), and with a pharmacogenomic profile, particularly in cases requiring pharmacotherapy or where patients are already on complex polypharmacy regimens